Filing Details

Accession Number:
0001021561-13-000112
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-13 18:53:08
Reporting Period:
2013-11-11
Filing Date:
2013-11-13
Accepted Time:
2013-11-13 18:53:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1021561 Nu Skin Enterprises Inc NUS Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 870565309
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184201 Y Joseph Chang C/O Nu Skin Enterprises, Inc.
75 West Center Street
Provo 84601
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2013-11-11 17,500 $26.13 116,597 No 4 M Direct
Class A Common Stock Acquisiton 2013-11-11 17,500 $22.33 134,097 No 4 M Direct
Class A Common Stock Acquisiton 2013-11-11 17,500 $21.34 151,597 No 4 M Direct
Class A Common Stock Acquisiton 2013-11-11 3,063 $17.03 154,660 No 4 M Direct
Class A Common Stock Disposition 2013-11-11 55,563 $111.63 99,097 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Disposition 2013-11-11 17,500 $0.00 17,500 $26.13
Class A Common Stock Employee Stock Option (right to buy) Disposition 2013-11-11 17,500 $0.00 17,500 $22.33
Class A Common Stock Employee Stock Option (right to buy) Disposition 2013-11-11 17,500 $0.00 17,500 $21.34
Class A Common Stock Employee Stock Option (right to buy) Disposition 2013-11-11 3,063 $0.00 3,063 $17.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-09-01 No 4 M Direct
0 2015-02-28 No 4 M Direct
0 2015-08-31 No 4 M Direct
0 2015-08-15 No 4 M Direct
Footnotes
  1. Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
  2. Currently exercisable in full.